Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Surgery Partners, Inc. (1SP.F)

Compare
18.20
-0.30
(-1.62%)
As of 8:05:02 AM GMT+2. Market Open.
Loading Chart for 1SP.F
  • Previous Close 18.50
  • Open 18.20
  • Bid 18.20 x 20900
  • Ask 18.60 x 20100
  • Day's Range 18.20 - 18.20
  • 52 Week Range 17.80 - 30.40
  • Volume 493
  • Avg. Volume 7
  • Market Cap (intraday) 2.323B
  • Beta (5Y Monthly) 2.40
  • PE Ratio (TTM) --
  • EPS (TTM) -1.17
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

15,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1SP.F

View More

Performance Overview: 1SP.F

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1SP.F
8.08%
S&P 500 (^GSPC)
8.25%

1-Year Return

1SP.F
21.55%
S&P 500 (^GSPC)
6.83%

3-Year Return

1SP.F
64.51%
S&P 500 (^GSPC)
22.86%

5-Year Return

1SP.F
211.11%
S&P 500 (^GSPC)
92.77%

Compare To: 1SP.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1SP.F

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    2.37B

  • Enterprise Value

    5.40B

  • Trailing P/E

    --

  • Forward P/E

    24.94

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.85

  • Price/Book (mrq)

    1.50

  • Enterprise Value/Revenue

    1.98

  • Enterprise Value/EBITDA

    12.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.40%

  • Return on Assets (ttm)

    4.01%

  • Return on Equity (ttm)

    0.36%

  • Revenue (ttm)

    3.11B

  • Net Income Avi to Common (ttm)

    -168.1M

  • Diluted EPS (ttm)

    -1.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    269.5M

  • Total Debt/Equity (mrq)

    102.14%

  • Levered Free Cash Flow (ttm)

    181.48M

Research Analysis: 1SP.F

View More

Company Insights: 1SP.F

Research Reports: 1SP.F

View More

People Also Watch